New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News

01/30

According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the "Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026)." The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the "soliciting opinions" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as "supplementing materials."

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1186833842"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186833842\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186833842?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 20:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186833842","market":"fut","top_or_hot":-1,"title":"New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission","media":"Stock News","content":"<p>According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-30 20:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1186833842","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186833842","pubTimestamp":1769776456,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","02565":"派格生物医药-B","BK1515":"抗疫概念","BK1161":"生物科技","BK1574":"生物医药B类股","09939":"开拓药业-B"},"translate_title":"新股快讯|香港IPO申请获证监会受理企业中的新济药业、逸飞科技","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"09939":1,"02565":1},"content_text":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}